Press release
Endometrial Cancer Treatment Market :The greatest challenges in the coming year
Overview-Endometrial cancer is the malignancy that develops in the layers of the cells that form the endometrium, the lining of the uterus. Women with high blood pressure, diabetes, or breast cancer are at a greater risk of being affected by endometrial cancer. It usually affect women post menopause, and the risk increases above the age of 40. Surgical procedure, chemotherapy, immunotherapy, targeted therapy, and brachytherapy are the treatment method of Endometrial Cancer. The global Endometrial Cancer Treatment Market is estimated to value over US$ 12.4 billion by 2027.
Drivers-
Endometrial cancer is one of the most prominently observed cancers in women. According to Cancer Organisation, Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. This leads to the growth of the Endometrial Cancer Treatment Market. In addition, new drug development and commercialization further contribute to the growth of this market.
Request for Exclusive sample report here https://www.worldwidemarketreports.com/sample/476543
Restraints-
Treatment of Endometrial Cancer is expensive. This restricts the growth of the Endometrial Cancer Treatment Market
Regional Insights-
North America is expected to dominate the global endometrial cancer market. This can be majorly attributed to increasing prevalence rates of endometrial cancers. For instance, according to Centers for Disease Control and Prevention, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. In addition, rising awareness for the diagnosis of cancer and the presence of the developed healthcare infrastructure are expected to propel the market in this region.
Competitive Section-
Some of the major players of the market are Bristol-Myers Squibb Company, Pfizer Inc., R-Pharm-US LLC, Elekta AB, and Varian Medical Systems, Inc.
In May 2017, Merck&Co. Inc. received approval from the US FDA for pembrolizumab, to treat tumors with specific genetic diseases including endometrial cancer
In August 2018, Merck&Co. Inc collaborated with Eisai Co. and received approval from the US FDA to combine Lenvatinib for the treatment of patients with Endometrial Cancer
If you have any questions on this report, please reach out to us @ https://www.worldwidemarketreports.com/quiry/476543
Contact Us:
Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com
Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometrial Cancer Treatment Market :The greatest challenges in the coming year here
News-ID: 2205472 • Views: …
More Releases from worldwidemarketreports
What are the different trends in Cash Logistics Market to boost its growth?
WorldwideMarket Reports has announced the addition of the “Cash Logistics Market to 2026”, the report classifies the global Cash Logistics Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth
This report studies the global Cash Logistics market, analyzes and researches the Cash Logistics development status and forecast in United States, EU, Japan, China, India and…
Robo-Taxi Market is expected to register a modest increase in the near-term asse …
A robotaxi also known as a self-driving taxi or a driverless taxi, is an autonomous car (SAE automation level 4 or 5) operated for a ridesharing company . The fact of eliminating the need for a human driver or chauffeur, which represents a significant part of the operating costs of that type of services, could make it a very affordable solution for the customers and accelerate the spreading of Transportation-as-a-Service…
Life Support Systems Market Expected to Beat Earnings Estimates
A life-support system is the combination of equipment that allows survival in an environment or situation that would not support that life in its absence. It is generally applied to systems supporting human life in situations where the outside environment is hostile, such as in space or underwater, or medical situations where the health of the person is compromised to the extent that the risk of death would be high…
Why 2021's ketone market has made young investors ‘excessively optimistic
In chemistry, a ketone is a functional group with the structure R2C=O, where R can be a variety of carbon-containing substituents. Ketones contain a carbonyl group (a carbon-oxygen double bond). The simplest ketone is acetone (R = R' = methyl), with the formula CH3C(O)CH3. Many ketones are of great importance in industry and in biology. Examples include many sugars (ketoses), many steroids (e.g., testosterone), and the solvent acetone.
The ketone…
More Releases for Endometrial
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endometrial Cancer Treatment Industry Market Size Be by 2025?
In recent years, the market size for endometrial cancer treatment has experienced consistent growth. It is projected to increase from $31.04 billion in 2024 to $32.09 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Endometrial Cancer Treatment Market Size and Projected Growth Rate?
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to…
Endometrial Biopsy Cannulae Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Endometrial Biopsy Cannulae market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth…
Hysteroscopic Endometrial Resection Market - Transforming Hysteroscopy, Enhancin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Hysteroscopic Endometrial Resection Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Hysteroscopic Endometrial Resection provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot
With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world.
Download The…
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR).
The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these…
